Buy TapImmune Stock | TPIV Stock Price & Latest News | Public
TPIV

TapImmune

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    About TPIV

    Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The ...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    Stats

    Market Cap$75,52M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$4.34
    1 Year Low$1.33
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app